Literature DB >> 15160256

Osteosarcoma associated with hyperparathyroidism.

Paul C Jutte1, Renato Rosso, Massimiliano de Paolis, Costatino Errani, Elisabetta Pasini, Laura Campanacci, Gaetano Bacci, Franco Bertoni, Mario Mercuri.   

Abstract

The fourth case in the literature is presented of a patient with the rare association of hyperparathyroidism and osteosarcoma. A 56-year-old woman presented with hyperparathyroidism and a lesion in the tibia. Initial diagnosis was brown tumor. Histology, however, revealed osteosarcoma, and the patient was treated accordingly. The experimental induction of osteosarcoma by parathormone in rodent studies makes this finding alarming, considering the increasing use of parathormone in the treatment of osteoporosis. The mechanism by which osteosarcoma is induced in humans cannot be explained based on current knowledge of mechanisms of action of parathyroid hormone.

Entities:  

Mesh:

Year:  2004        PMID: 15160256     DOI: 10.1007/s00256-004-0771-0

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  8 in total

1.  Recombinant human parathyroid hormone.

Authors:  Jonathan Reeve
Journal:  BMJ       Date:  2002-02-23

2.  Osteosarcoma risk in rats using PTH 1-34.

Authors:  E K Barbehenn; P Lurie; S M Wolfe
Journal:  Trends Endocrinol Metab       Date:  2001-11       Impact factor: 12.015

3.  Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed.

Authors:  Gemma Kuijpers; Bruce Schneider; Bruce Stadel; Eric Colman
Journal:  BMJ       Date:  2002-05-18

4.  Teriparatide: a novel agent that builds new bone.

Authors:  Trish R Freeman
Journal:  J Am Pharm Assoc (2003)       Date:  2003 Jul-Aug

5.  Hyperparathyroidism associated with sarcoma of bone.

Authors:  J Smith; A G Huvos; M Chapman; C Rabbs; R H Spiro
Journal:  Skeletal Radiol       Date:  1997-02       Impact factor: 2.199

6.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

7.  Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Authors:  John L Vahle; Masahiko Sato; Gerald G Long; Jamie K Young; Paul C Francis; Jeffery A Engelhardt; Michael S Westmore; Yanfei Linda; James B Nold
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

8.  Osteosarcoma of bone in apatient with primary hyperparathyroidism: a case report.

Authors:  M Betancourt; K L Wirfel; A K Raymond; A W Yasko; J Lee; R Vassilopoulou-Sellin
Journal:  J Bone Miner Res       Date:  2003-01       Impact factor: 6.741

  8 in total
  2 in total

1.  Presumed osteosarcoma.

Authors:  Ralph Kettritz; Nilufar Mohebbi; Theresa Claus; Ute Kettritz; Wolfgang Schneider; Friedrich C Luft
Journal:  Clin Kidney J       Date:  2013-05-03

2.  Undifferentiated Pleomorphic Sarcoma and Hyperparathyroidism in an Adolescent Male: A Case Report and Review of Hyperparathyroidism-associated Sarcomas.

Authors:  Stephen A Herrmann; Rupert Stanborough; John S A Chrisinger; Jack W Jennings
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.